/THKKF
THKKF Stock - Think Research Corporation
Healthcare|Medical - Healthcare Information ServicesOTC
$0.23-1.74%
$0.00 (-1.74%) • Apr 16
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.77
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for THKKF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.22 – $0.23
TARGET (TP)$0.26
STOP LOSS$0.21
RISK/REWARD1:2.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.76
52W High$0.36
52W Low$0.15
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Revenue | $78.60M | $47.79M | $19.44M |
| Gross Profit | $37.39M | $24.40M | $11.93M |
| Gross Margin | 47.6% | 51.0% | 61.4% |
| Operating Income | $-19,842,000 | $-21,818,000 | $-8,857,000 |
| Net Income | $-25,743,000 | $-29,049,000 | $-10,016,000 |
| Net Margin | -32.8% | -60.8% | -51.5% |
| EPS | $-0.42 | $-0.62 | $-0.28 |
Company Overview
Think Research Corporation, together with its subsidiaries, gathers, develops, and delivers knowledge-based Software-as-a-Service solutions for the health care industry in Canada, the United States, and internationally. The company's products portfolio comprises order sets that structures clinical pathway at the point of care; eReferrals that allows physicians to find and refer specialists directly from EMR systems; VirtualCare, which allows clinicians and allied health professionals to replace in-person appointments with virtual visits; and eForms, a real-time analytics to track resident volumes, signature adherence, and compliance; and COVID-19 clinical tools, as well as clinical support tools for long-term care. Think Research Corporation is based in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
THKKFBeat Rate
25%
Last 12 quarters
Avg Surprise
-59.5%
EPS vs Estimate
Beats / Misses
3/7
2 met exactly
Latest EPS
$-0.04
Q4 2023
EPS Surprise History
Q2 22
-9.1%
$-0.12vs$-0.11
Q2 22
-5.6%
$-0.08vs$-0.08
Q3 22
0.0%
$-0.13vs$-0.13
Q4 22
0.0%
$-0.11vs$-0.11
Q2 23
-42.1%
$-0.07vs$-0.05
Q2 23
+27.5%
$-0.03vs$-0.05
Q3 23
+40.0%
$-0.02vs$-0.04
Q4 23
+9.1%
$-0.04vs$-0.04
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 27, 2024 | — | — | — | — |
Q2 2024 | Apr 29, 2024 | — | — | — | — |
Q4 2023 | Nov 27, 2023 | $-0.04 | $-0.04 | +9.1% | ✓ BEAT |
Q3 2023 | Aug 29, 2023 | $-0.04 | $-0.02 | +40.0% | ✓ BEAT |
Q2 2023 | May 29, 2023 | $-0.05 | $-0.03 | +27.5% | ✓ BEAT |
Q2 2023 | May 1, 2023 | $-0.05 | $-0.07 | -42.1% | ✗ MISS |
Q4 2022 | Nov 28, 2022 | $-0.11 | $-0.11 | 0.0% | = MET |
Q3 2022 | Aug 29, 2022 | $-0.13 | $-0.13 | 0.0% | = MET |
Q2 2022 | May 30, 2022 | $-0.08 | $-0.08 | -5.6% | ✗ MISS |
Q2 2022 | May 2, 2022 | $-0.11 | $-0.12 | -9.1% | ✗ MISS |
Q4 2021 | Nov 29, 2021 | $-0.11 | $-0.24 | -118.2% | ✗ MISS |
Q3 2021 | Aug 23, 2021 | $-0.07 | $-0.13 | -85.7% | ✗ MISS |
Q2 2021 | May 13, 2021 | $-0.05 | $-0.12 | -140.0% | ✗ MISS |
Q2 2021 | Apr 28, 2021 | $-0.10 | $-0.49 | -390.0% | ✗ MISS |
Q4 2020 | Nov 30, 2020 | — | $-0.01 | — | — |
Q3 2020 | Aug 28, 2020 | — | — | — | — |
Q2 2020 | May 26, 2020 | — | — | — | — |
Q2 2020 | Apr 27, 2020 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about THKKF
What is THKKF's current stock price?
Think Research Corporation (THKKF) is currently trading at $0.23 per share. The stock has moved -1.74% today.
What is the analyst price target for THKKF?
No analyst price targets are currently available for this stock.
What sector is Think Research Corporation in?
Think Research Corporation operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.
What is THKKF's market cap?
Think Research Corporation has a market capitalization of $0.02 billion, making it a small-cap company.
Does THKKF pay dividends?
No, Think Research Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATHJF
Antisense Therapeutics Limited
$0.01
Mkt Cap: $0.0B
DIZTF
Dignitana AB (publ)
$0.22
Mkt Cap: $0.0B
HDSLF
HS GovTech Solutions Inc.
$0.39
Mkt Cap: $0.0B
MNNDF
Nurosene Health Inc.
$0.33
Mkt Cap: $0.0B
NOXOF
Noxopharm Limited
$0.04
Mkt Cap: $0.0B
NXTTF
Lifeist Wellness Inc.
$0.04
Mkt Cap: $0.0B
OCEL
Organicell Regenerative Medicine, Inc.
$2.74
Mkt Cap: $0.0B
RAMMF
RAMM Pharma Corp.
$0.06
Mkt Cap: $0.0B
RTNXF
Renalytix Plc
$0.08
Mkt Cap: $0.0B
SRNEQ
Sorrento Therapeutics, Inc.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to THKKF for comparison